Structure

Physi-Chem Properties

Molecular Weight:  608.15
Volume:  581.949
LogP:  3.511
LogD:  2.532
LogS:  -4.366
# Rotatable Bonds:  9
TPSA:  205.58
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.125
Synthetic Accessibility Score:  4.146
Fsp3:  0.226
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.189
MDCK Permeability:  2.2534679374075495e-05
Pgp-inhibitor:  0.023
Pgp-substrate:  0.912
Human Intestinal Absorption (HIA):  0.507
20% Bioavailability (F20%):  0.211
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  99.9837417602539%
Volume Distribution (VD):  0.527
Pgp-substrate:  4.621647834777832%

ADMET: Metabolism

CYP1A2-inhibitor:  0.573
CYP1A2-substrate:  0.088
CYP2C19-inhibitor:  0.33
CYP2C19-substrate:  0.056
CYP2C9-inhibitor:  0.759
CYP2C9-substrate:  0.878
CYP2D6-inhibitor:  0.654
CYP2D6-substrate:  0.456
CYP3A4-inhibitor:  0.394
CYP3A4-substrate:  0.096

ADMET: Excretion

Clearance (CL):  4.73
Half-life (T1/2):  0.767

ADMET: Toxicity

hERG Blockers:  0.206
Human Hepatotoxicity (H-HT):  0.149
Drug-inuced Liver Injury (DILI):  0.817
AMES Toxicity:  0.703
Rat Oral Acute Toxicity:  0.031
Maximum Recommended Daily Dose:  0.166
Skin Sensitization:  0.951
Carcinogencity:  0.378
Eye Corrosion:  0.003
Eye Irritation:  0.286
Respiratory Toxicity:  0.039

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472993

Natural Product ID:  NPC472993
Common Name*:   RFBRMMMSAPRGDM-TUYFOBMESA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  RFBRMMMSAPRGDM-TUYFOBMESA-N
Standard InCHI:  InChI=1S/C31H28O13/c1-40-23-10-15(2-8-19(23)33)3-9-26(36)41-14-25-28(37)29(38)30(39)31(44-25)42-18-11-20(34)27-21(35)13-22(43-24(27)12-18)16-4-6-17(32)7-5-16/h2-13,25,28-34,37-39H,14H2,1H3/b9-3+/t25-,28-,29+,30-,31-/m1/s1
SMILES:  COC1=C(C=CC(=C1)C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3597471
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[20356064]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[22283497]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota leaf Putz City, Chiayi County, Taiwan 2009-Nov PMID[25999202]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[28742368]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[29397715]
NPO26700 Tinospora crispa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 8800.0 nM PMID[463197]
NPT35 Others n.a. Retention_time = 41.8 min PMID[463197]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472993 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9817 High Similarity NPC217520
0.9817 High Similarity NPC139571
0.9758 High Similarity NPC471030
0.9756 High Similarity NPC472991
0.9756 High Similarity NPC472992
0.9755 High Similarity NPC88560
0.9755 High Similarity NPC172033
0.9755 High Similarity NPC175230
0.9753 High Similarity NPC149011
0.9753 High Similarity NPC204937
0.9697 High Similarity NPC477895
0.9697 High Similarity NPC35167
0.9695 High Similarity NPC34267
0.9695 High Similarity NPC81042
0.9695 High Similarity NPC223426
0.9695 High Similarity NPC214621
0.9693 High Similarity NPC47140
0.9693 High Similarity NPC67134
0.9641 High Similarity NPC36138
0.9641 High Similarity NPC35924
0.9641 High Similarity NPC199172
0.9636 High Similarity NPC144097
0.9636 High Similarity NPC61904
0.9632 High Similarity NPC231194
0.9632 High Similarity NPC51326
0.963 High Similarity NPC116745
0.963 High Similarity NPC229729
0.9627 High Similarity NPC311830
0.9627 High Similarity NPC22832
0.9583 High Similarity NPC470720
0.9583 High Similarity NPC470713
0.9583 High Similarity NPC470717
0.9583 High Similarity NPC460984
0.9583 High Similarity NPC470416
0.9583 High Similarity NPC25946
0.9583 High Similarity NPC21359
0.9578 High Similarity NPC217387
0.9578 High Similarity NPC258044
0.9578 High Similarity NPC476623
0.9578 High Similarity NPC37668
0.9578 High Similarity NPC196127
0.9578 High Similarity NPC476621
0.9578 High Similarity NPC476620
0.9578 High Similarity NPC472387
0.9578 High Similarity NPC267680
0.9578 High Similarity NPC113836
0.9578 High Similarity NPC476619
0.9578 High Similarity NPC476622
0.9578 High Similarity NPC293626
0.9578 High Similarity NPC253521
0.9578 High Similarity NPC476618
0.9573 High Similarity NPC211594
0.9573 High Similarity NPC254540
0.9573 High Similarity NPC153755
0.9573 High Similarity NPC172807
0.9571 High Similarity NPC195257
0.9571 High Similarity NPC209296
0.9568 High Similarity NPC115674
0.9568 High Similarity NPC210073
0.9565 High Similarity NPC222936
0.9565 High Similarity NPC270335
0.9565 High Similarity NPC88023
0.9565 High Similarity NPC243930
0.9565 High Similarity NPC284960
0.9565 High Similarity NPC168822
0.9565 High Similarity NPC309025
0.9565 High Similarity NPC191306
0.9565 High Similarity NPC19709
0.9527 High Similarity NPC474093
0.9527 High Similarity NPC473554
0.9527 High Similarity NPC470719
0.9527 High Similarity NPC104910
0.9527 High Similarity NPC295625
0.9524 High Similarity NPC470718
0.9524 High Similarity NPC241781
0.9524 High Similarity NPC156785
0.9524 High Similarity NPC162394
0.9515 High Similarity NPC4390
0.9512 High Similarity NPC244776
0.9512 High Similarity NPC116864
0.9512 High Similarity NPC206123
0.9503 High Similarity NPC473043
0.9503 High Similarity NPC189142
0.9503 High Similarity NPC77660
0.9471 High Similarity NPC475179
0.9467 High Similarity NPC249560
0.9467 High Similarity NPC223860
0.9467 High Similarity NPC275977
0.9461 High Similarity NPC173837
0.9461 High Similarity NPC120952
0.9458 High Similarity NPC477848
0.9455 High Similarity NPC235575
0.9455 High Similarity NPC205076
0.9455 High Similarity NPC307518
0.9455 High Similarity NPC190003
0.9455 High Similarity NPC175107
0.9455 High Similarity NPC48773
0.9455 High Similarity NPC256760
0.9451 High Similarity NPC186807
0.9451 High Similarity NPC105025
0.9451 High Similarity NPC219904
0.9451 High Similarity NPC223747
0.9451 High Similarity NPC45638
0.9451 High Similarity NPC469931
0.9451 High Similarity NPC86008
0.9451 High Similarity NPC120099
0.9451 High Similarity NPC225434
0.9451 High Similarity NPC93337
0.9451 High Similarity NPC201292
0.9451 High Similarity NPC226294
0.9451 High Similarity NPC58053
0.9451 High Similarity NPC475942
0.9451 High Similarity NPC229687
0.9451 High Similarity NPC203050
0.9448 High Similarity NPC8856
0.9448 High Similarity NPC21100
0.9448 High Similarity NPC197285
0.9448 High Similarity NPC236934
0.9448 High Similarity NPC5778
0.9444 High Similarity NPC88043
0.9441 High Similarity NPC305987
0.9441 High Similarity NPC84324
0.9441 High Similarity NPC472994
0.9441 High Similarity NPC477629
0.9441 High Similarity NPC182045
0.9441 High Similarity NPC195685
0.9441 High Similarity NPC270675
0.9441 High Similarity NPC113163
0.9441 High Similarity NPC477628
0.9441 High Similarity NPC210961
0.9441 High Similarity NPC66618
0.9441 High Similarity NPC288131
0.9441 High Similarity NPC165970
0.9412 High Similarity NPC33083
0.9408 High Similarity NPC135831
0.9408 High Similarity NPC297503
0.9408 High Similarity NPC97119
0.9401 High Similarity NPC472385
0.9401 High Similarity NPC198324
0.9401 High Similarity NPC296018
0.9401 High Similarity NPC471669
0.9401 High Similarity NPC154741
0.9401 High Similarity NPC233994
0.9401 High Similarity NPC211532
0.9401 High Similarity NPC89127
0.9398 High Similarity NPC204693
0.9398 High Similarity NPC208668
0.9394 High Similarity NPC285197
0.9394 High Similarity NPC44328
0.9394 High Similarity NPC95866
0.9394 High Similarity NPC105511
0.9394 High Similarity NPC224462
0.9394 High Similarity NPC155763
0.9394 High Similarity NPC150767
0.9394 High Similarity NPC105095
0.9394 High Similarity NPC79056
0.9394 High Similarity NPC177731
0.9394 High Similarity NPC67105
0.9394 High Similarity NPC78734
0.9394 High Similarity NPC20505
0.9394 High Similarity NPC235260
0.939 High Similarity NPC84362
0.939 High Similarity NPC45618
0.939 High Similarity NPC58716
0.939 High Similarity NPC173637
0.939 High Similarity NPC226304
0.939 High Similarity NPC265530
0.939 High Similarity NPC52550
0.939 High Similarity NPC45400
0.939 High Similarity NPC317489
0.939 High Similarity NPC127546
0.939 High Similarity NPC325555
0.939 High Similarity NPC146792
0.939 High Similarity NPC223424
0.9387 High Similarity NPC475366
0.9387 High Similarity NPC139060
0.9387 High Similarity NPC277205
0.9387 High Similarity NPC475497
0.9387 High Similarity NPC165720
0.9387 High Similarity NPC284277
0.9383 High Similarity NPC285108
0.9383 High Similarity NPC33298
0.9383 High Similarity NPC300537
0.9383 High Similarity NPC127782
0.9379 High Similarity NPC110349
0.9379 High Similarity NPC101731
0.9357 High Similarity NPC97817
0.9357 High Similarity NPC30011
0.9357 High Similarity NPC72554
0.9349 High Similarity NPC469371
0.9345 High Similarity NPC476773
0.9341 High Similarity NPC237435
0.9341 High Similarity NPC220173
0.9341 High Similarity NPC101191
0.9341 High Similarity NPC115760
0.9341 High Similarity NPC198199
0.9341 High Similarity NPC253685
0.9341 High Similarity NPC473327
0.9341 High Similarity NPC16194
0.9341 High Similarity NPC19108

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472993 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9571 High Similarity NPD7054 Approved
0.9512 High Similarity NPD7472 Approved
0.9394 High Similarity NPD7074 Phase 3
0.9341 High Similarity NPD4338 Clinical (unspecified phase)
0.9337 High Similarity NPD6797 Phase 2
0.9281 High Similarity NPD7251 Discontinued
0.9273 High Similarity NPD3818 Discontinued
0.9226 High Similarity NPD7808 Phase 3
0.9152 High Similarity NPD6167 Clinical (unspecified phase)
0.9152 High Similarity NPD6168 Clinical (unspecified phase)
0.9152 High Similarity NPD6166 Phase 2
0.9136 High Similarity NPD4381 Clinical (unspecified phase)
0.8957 High Similarity NPD4868 Clinical (unspecified phase)
0.8889 High Similarity NPD1934 Approved
0.878 High Similarity NPD3817 Phase 2
0.8765 High Similarity NPD7804 Clinical (unspecified phase)
0.872 High Similarity NPD2801 Approved
0.872 High Similarity NPD2393 Clinical (unspecified phase)
0.8663 High Similarity NPD7993 Clinical (unspecified phase)
0.8613 High Similarity NPD6559 Discontinued
0.8537 High Similarity NPD4380 Phase 2
0.8509 High Similarity NPD1511 Approved
0.8503 High Similarity NPD3882 Suspended
0.8452 Intermediate Similarity NPD7075 Discontinued
0.8439 Intermediate Similarity NPD5844 Phase 1
0.8415 Intermediate Similarity NPD1653 Approved
0.8405 Intermediate Similarity NPD1512 Approved
0.8373 Intermediate Similarity NPD7411 Suspended
0.8354 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD5402 Approved
0.8323 Intermediate Similarity NPD6801 Discontinued
0.8274 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD6232 Discontinued
0.8242 Intermediate Similarity NPD5403 Approved
0.8218 Intermediate Similarity NPD7473 Discontinued
0.8202 Intermediate Similarity NPD8313 Approved
0.8202 Intermediate Similarity NPD8312 Approved
0.8198 Intermediate Similarity NPD7199 Phase 2
0.8192 Intermediate Similarity NPD7685 Pre-registration
0.8187 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8177 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD6799 Approved
0.8171 Intermediate Similarity NPD7228 Approved
0.8166 Intermediate Similarity NPD1465 Phase 2
0.8166 Intermediate Similarity NPD7819 Suspended
0.8161 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD5494 Approved
0.8121 Intermediate Similarity NPD5401 Approved
0.8121 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD6959 Discontinued
0.8086 Intermediate Similarity NPD1549 Phase 2
0.8025 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7977 Intermediate Similarity NPD6234 Discontinued
0.7966 Intermediate Similarity NPD3751 Discontinued
0.7963 Intermediate Similarity NPD2796 Approved
0.7952 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD8151 Discontinued
0.7914 Intermediate Similarity NPD7266 Discontinued
0.7912 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD1510 Phase 2
0.7895 Intermediate Similarity NPD37 Approved
0.7882 Intermediate Similarity NPD6599 Discontinued
0.7879 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD4967 Phase 2
0.7861 Intermediate Similarity NPD7768 Phase 2
0.7861 Intermediate Similarity NPD4965 Approved
0.7861 Intermediate Similarity NPD4966 Approved
0.7849 Intermediate Similarity NPD8455 Phase 2
0.7841 Intermediate Similarity NPD3787 Discontinued
0.7826 Intermediate Similarity NPD1933 Approved
0.7816 Intermediate Similarity NPD3749 Approved
0.7771 Intermediate Similarity NPD919 Approved
0.7771 Intermediate Similarity NPD3750 Approved
0.776 Intermediate Similarity NPD7435 Discontinued
0.7758 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD6190 Approved
0.7716 Intermediate Similarity NPD230 Phase 1
0.7711 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7696 Intermediate Similarity NPD6782 Approved
0.7696 Intermediate Similarity NPD6779 Approved
0.7696 Intermediate Similarity NPD6778 Approved
0.7696 Intermediate Similarity NPD6776 Approved
0.7696 Intermediate Similarity NPD6777 Approved
0.7696 Intermediate Similarity NPD6780 Approved
0.7696 Intermediate Similarity NPD6781 Approved
0.7692 Intermediate Similarity NPD7240 Approved
0.7665 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD7783 Phase 2
0.7665 Intermediate Similarity NPD4628 Phase 3
0.7654 Intermediate Similarity NPD1240 Approved
0.7654 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1613 Approved
0.7641 Intermediate Similarity NPD7584 Approved
0.7636 Intermediate Similarity NPD1551 Phase 2
0.7632 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD447 Suspended
0.7598 Intermediate Similarity NPD3926 Phase 2
0.7561 Intermediate Similarity NPD1607 Approved
0.7546 Intermediate Similarity NPD943 Approved
0.7538 Intermediate Similarity NPD7871 Phase 2
0.7538 Intermediate Similarity NPD7870 Phase 2
0.7531 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2935 Discontinued
0.7525 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD7874 Approved
0.7514 Intermediate Similarity NPD7458 Discontinued
0.7487 Intermediate Similarity NPD7696 Phase 3
0.7487 Intermediate Similarity NPD7697 Approved
0.7487 Intermediate Similarity NPD7698 Approved
0.7486 Intermediate Similarity NPD1247 Approved
0.7485 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD3748 Approved
0.7469 Intermediate Similarity NPD3027 Phase 3
0.7436 Intermediate Similarity NPD6823 Phase 2
0.7435 Intermediate Similarity NPD6534 Approved
0.7435 Intermediate Similarity NPD6535 Approved
0.7424 Intermediate Similarity NPD7701 Phase 2
0.7424 Intermediate Similarity NPD7585 Approved
0.7414 Intermediate Similarity NPD3226 Approved
0.7407 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD920 Approved
0.7398 Intermediate Similarity NPD7680 Approved
0.7394 Intermediate Similarity NPD8150 Discontinued
0.7384 Intermediate Similarity NPD2534 Approved
0.7384 Intermediate Similarity NPD2532 Approved
0.7384 Intermediate Similarity NPD2533 Approved
0.7374 Intermediate Similarity NPD7583 Approved
0.7371 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD8320 Phase 1
0.736 Intermediate Similarity NPD8319 Approved
0.7351 Intermediate Similarity NPD5953 Discontinued
0.7346 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7699 Phase 2
0.732 Intermediate Similarity NPD7700 Phase 2
0.7314 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7313 Intermediate Similarity NPD7801 Approved
0.7301 Intermediate Similarity NPD6832 Phase 2
0.7294 Intermediate Similarity NPD1243 Approved
0.7283 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7549 Discontinued
0.7267 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD7033 Discontinued
0.7246 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD7286 Phase 2
0.7225 Intermediate Similarity NPD7390 Discontinued
0.7222 Intermediate Similarity NPD1203 Approved
0.7219 Intermediate Similarity NPD7039 Approved
0.7219 Intermediate Similarity NPD7038 Approved
0.7212 Intermediate Similarity NPD2313 Discontinued
0.7212 Intermediate Similarity NPD6798 Discontinued
0.7211 Intermediate Similarity NPD8434 Phase 2
0.7207 Intermediate Similarity NPD5353 Approved
0.7202 Intermediate Similarity NPD6212 Phase 3
0.7202 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6213 Phase 3
0.7198 Intermediate Similarity NPD8127 Discontinued
0.7195 Intermediate Similarity NPD4908 Phase 1
0.7193 Intermediate Similarity NPD1652 Phase 2
0.7193 Intermediate Similarity NPD6674 Discontinued
0.7186 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD2346 Discontinued
0.7174 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6233 Phase 2
0.716 Intermediate Similarity NPD2799 Discontinued
0.716 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD9494 Approved
0.712 Intermediate Similarity NPD5242 Approved
0.7108 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD6844 Discontinued
0.7095 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD2800 Approved
0.709 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5124 Phase 1
0.7081 Intermediate Similarity NPD1091 Approved
0.7077 Intermediate Similarity NPD4360 Phase 2
0.7077 Intermediate Similarity NPD4363 Phase 3
0.7076 Intermediate Similarity NPD2344 Approved
0.7073 Intermediate Similarity NPD2798 Approved
0.7039 Intermediate Similarity NPD6386 Approved
0.7039 Intermediate Similarity NPD6385 Approved
0.7037 Intermediate Similarity NPD9269 Phase 2
0.7037 Intermediate Similarity NPD9717 Approved
0.7018 Intermediate Similarity NPD6099 Approved
0.7018 Intermediate Similarity NPD6100 Approved
0.7016 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD3268 Approved
0.7 Intermediate Similarity NPD5005 Approved
0.7 Intermediate Similarity NPD5006 Approved
0.7 Intermediate Similarity NPD7097 Phase 1
0.6989 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6975 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6975 Remote Similarity NPD422 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data